Comparable stake leader
FMR LLC
SEC ownership of 10x Genomics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001770787.
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
16 Jun 2026
- Public ticker
- TXG on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
FMR LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
FMR LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
16 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001770787
- Issuer location
- Pleasanton, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of 10x Genomics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
16 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 16%
13D/G row: FMR LLC
Showing 1-8 of 50 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 16%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
16%
VANGUARD GROUP INC
12%
ARK Investment Management LLC
10%
BlackRock, Inc.
7.6%
Sumitomo Mitsui Trust Group, Inc.
4.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
Company
|
16%
from 13D/G
|
$376,640,828
17,740,972 shares
|
— | 31 Mar 2026 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
12%
|
$155,176,941
13,274,332 shares
|
$0 | 30 Sep 2025 |
| ARK Investment Management LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$248,758,647
11,717,317 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.6%
from 13D/G
|
$213,996,552
10,079,913 shares
|
— | 31 Mar 2026 |
| Sumitomo Mitsui Trust Group, Inc. |
13F
13D/G
Company
|
4.7%
from 13D/G
|
$108,489,843
5,110,214 shares
|
— | 31 Mar 2026 |
| Amova Asset Management Americas, Inc. |
13F
13D/G
Company
|
4.7%
from 13D/G
|
$108,310,657
5,104,178 shares
|
— | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
Company
|
2.7%
from 13D/G
|
$43,912,429
2,068,414 shares
|
— | 31 Mar 2026 |
| Benjamin J. Hindson |
3/4/5
Title: President and Chief Scientific Officer, Director
|
0.42%
|
$12,269,633
502,000 shares
|
-$689,350 | 22 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$5,173,195.
Buys
$0
Insiders: 0
Sells
$5,173,195
Insiders: 5
Net
-$5,173,195
Shares: -234,047
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 234,047
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 91,309 | $0 | $2,581,499 | -$2,581,499 |
| 3-6 | 0 | 70,157 | $0 | $1,416,797 | -$1,416,797 |
| 6-9 | 0 | 33,432 | $0 | $635,151 | -$635,151 |
| 9-12 | 0 | 39,149 | $0 | $539,747 | -$539,747 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to 10x Genomics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Bryan E. Roberts
Net 12M change
-$5,173,194
Latest report
22 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bryan E. Roberts | Director | $195,830,277 | Mixed | 14 Jun 2023 | ||
| Serge Saxonov | Chief Executive Officer, Director | $104,696,135 | -$3,080,860 | -2.9% | Mixed | 22 Jun 2026 |
| Benjamin J. Hindson | Title: President and Chief Scientific Officer, Director | $12,269,633 | -$689,350 | -5.3% | Filing P/S | 22 May 2026 |
| Adam Taich | Chief Financial Officer | $9,285,276 | -$1,069,120 | -10% | Filing P/S | 22 May 2026 |
| John R. Stuelpnagel | Director | $7,821,896 | Mixed | 04 Jun 2026 | ||
| Bradford Crutchfield | former officer | $4,438,548 | Mixed | 29 Jul 2022 | ||
| Mathai Mammen | Director | $4,380,943 | Mixed | 11 Jun 2024 | ||
| James Wilbur | Chief Commercial Officer | $3,804,287 | Mixed | 22 Nov 2023 | ||
| Justin J. McAnear | Former Chief Financial Officer | $3,227,199 | Filing P/S | 22 Aug 2024 | ||
| Alan Mateo | Director | $1,823,168 | Mixed | 04 Jun 2026 | ||
| Sridhar Kosaraju | Director | $1,449,541 | Mixed | 04 Jun 2026 | ||
| Shehnaaz Suliman | Director | $1,055,511 | -$186,756 | -15% | Filing P/S | 16 Jun 2026 |
| Kimberly J. Popovits | Director | $794,957 | Mixed | 04 Jun 2026 | ||
| Sarah A. Teichmann | Director | $755,979 | -$147,108 | -16% | Mixed | 04 Jun 2026 |
Recent insider transactions for 10x Genomics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Serge Saxonov | TXG | Class A Common Stock | Sale | -2.64% | $1,033,269 | $34.44 | -30,000 | 1,108,380 | 22 Jun 2026 | Direct |
| Shehnaaz Suliman | TXG | Class A Common Stock | Sale | -15.3% | $186,756 | $32.63 | -5,723 | 31,722 | 16 Jun 2026 | Direct |
| Sarah A. Teichmann | TXG | Class A Common Stock | Award | 33% | 8,829 | 35,609 | 04 Jun 2026 | Direct | ||
| Shehnaaz Suliman | TXG | Class A Common Stock | Award | 30.8% | 8,829 | 37,445 | 04 Jun 2026 | Direct | ||
| John R. Stuelpnagel | TXG | Class A Common Stock | Award | 2.46% | 8,829 | 368,436 | 04 Jun 2026 | Direct | ||
| Kimberly J. Popovits | TXG | Class A Common Stock | Award | 30.8% | 8,829 | 37,445 | 04 Jun 2026 | Direct | ||
| Alan Mateo | TXG | Class A Common Stock | Award | 11.5% | 8,829 | 85,877 | 04 Jun 2026 | Direct | ||
| Sridhar Kosaraju | TXG | Class A Common Stock | Award | 15.6% | 8,829 | 65,278 | 04 Jun 2026 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.93% | $264,833 | $24.71 | -10,718 | 1,138,380 | 26 May 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -1.56% | $444,224 | $24.44 | -18,175 | 1,149,098 | 22 May 2026 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -2.26% | $283,399 | $24.44 | -11,595 | 502,000 | 22 May 2026 | Direct |
| Adam Taich | TXG | Class A Common Stock | Sale | -3.82% | $369,018 | $24.44 | -15,098 | 379,898 | 22 May 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.43% | $122,784 | $24.56 | -5,000 | 1,167,273 | 14 Apr 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.42% | $97,612 | $19.52 | -5,000 | 1,172,273 | 24 Mar 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.84% | $191,297 | $19.13 | -10,000 | 1,177,273 | 23 Mar 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Gift | -0.23% | -2,750 | 1,200,917 | 03 Mar 2026 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Sale | -1.32% | $367,097 | $22.73 | -16,152 | 1,203,667 | 02 Mar 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Award | 14.9% | 157,895 | 1,219,819 | 26 Feb 2026 | Direct | ||
| Benjamin J. Hindson | TXG | Class A Common Stock | Award | 20.9% | 88,816 | 513,595 | 26 Feb 2026 | Direct | ||
| Adam Taich | TXG | Class A Common Stock | Award | 37% | 106,579 | 394,996 | 26 Feb 2026 | Direct | ||
| Sarah A. Teichmann | TXG | Class A Common Stock | Sale | -22.1% | $147,108 | $19.41 | -7,579 | 26,780 | 25 Feb 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.9% | $178,928 | $18.58 | -9,632 | 1,061,924 | 23 Feb 2026 | Direct |
| Adam Taich | TXG | Class A Common Stock | Sale | -3.02% | $166,593 | $18.58 | -8,968 | 288,417 | 23 Feb 2026 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.81% | $145,379 | $18.58 | -7,826 | 424,779 | 23 Feb 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Options Exercise | 4.89% | 50,000 | 1,071,556 | 05 Jan 2026 | Direct | ||
| Serge Saxonov | TXG | Stock Option (right to buy) | Options Exercise | -100% | -50,000 | 0 | 05 Jan 2026 | Direct | ||
| Adam Taich | TXG | Class A Common Stock | Sale | -3.84% | $225,852 | $19.00 | -11,888 | 297,385 | 24 Nov 2025 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.88% | $157,363 | $19.00 | -8,283 | 432,605 | 24 Nov 2025 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -1.28% | $251,936 | $19.00 | -13,261 | 1,021,556 | 24 Nov 2025 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Gift | -0.09% | -900 | 1,034,817 | 12 Sep 2025 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.98% | $128,881 | $13.79 | -9,348 | 945,892 | 22 Aug 2025 | Direct |
| Adam Taich | TXG | Class A Common Stock | Sale | -6.73% | $307,657 | $13.79 | -22,315 | 309,273 | 22 Aug 2025 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.67% | $103,209 | $13.79 | -7,486 | 440,888 | 22 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.